This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

This RF Safe commentary argues that dismissing the National Toxicology Program (NTP) cellphone-radiation animal findings as “too high dose” is misleading because the NTP used multiple exposure tiers, including a lowest tier described as near regulatory relevance. It also claims FDA has removed webpages containing prior “safety conclusion” language while HHS has announced a new study on electromagnetic radiation and health effects, framing these as a meaningful shift in federal public-facing posture. The piece further points to the Ramazzini Institute animal study as suggesting similar tumor signals at lower exposure levels, while acknowledging animal studies alone do not establish human causation.

RF Safe argues that recent WHO-linked evidence reviews have moved beyond a “thermal-only” safety narrative and that policy should respond with stronger protections. The post cites a 2025 WHO-commissioned systematic review in Environment International as concluding with “high certainty” that RF-EMF increases malignant heart schwannomas and brain gliomas in male rats, and references a 2025 corrigendum upgrading certainty for reduced pregnancy rates after male RF exposure in animal experiments. It also points to U.S. FCC rules being rooted in 1996-era assumptions and references a U.S. appellate court remand requiring the FCC to better address non-cancer harms and impacts on children and long-term exposure. The article advocates for the “Clean Ether Act” and promotes RF Safe’s proposed “S4–Mito–Spin” mechanism framework as a non-thermal explanatory model.

RF Safe argues for a transition from microwave-based wireless (cellular/Wi‑Fi/Bluetooth) to light-based communications (e.g., Li‑Fi) to reduce indoor RF exposure. The piece claims chronic, low-level RF exposure may pose health risks beyond heating and calls for a precautionary approach, while also criticizing U.S. legal and regulatory frameworks it says limit local control and rely on older, heat-focused assumptions.

RF Safe argues that a proposed “S4-Mito-Spin” framework explains non-thermal EMF biological effects and that current exposure standards (e.g., FCC/ICNIRP) are outdated because they focus on thermal limits. The article links EMF exposure to mechanisms involving voltage-gated ion channels (S4 segments), mitochondrial/NOX-driven oxidative stress, and radical-pair (spin) chemistry, and claims these mechanisms align with reported animal and human observations. It calls for regulatory overhaul and policy changes, citing various studies and legal/policy references, but presents these as advocacy claims rather than a balanced review.

RF Safe describes “S4-Mito-Spin” as a proposed framework for explaining non-thermal biological effects from RF/EMF exposures (phones, Wi‑Fi, cell towers). The article argues the model links three mechanisms—voltage-gated ion channel disruption, mitochondrial oxidative stress, and spin-dependent chemistry—to reported findings such as oxidative damage, circulation changes, and tumors in certain tissues. It cites animal studies (e.g., NTP and Ramazzini) and various 2025 claims (e.g., WHO review, sperm studies, embryo methylation, and ultrasound observations) to support a precautionary interpretation, while acknowledging ongoing debate and non-linear dose-response arguments.

RF Safe presents “S4 MITO spin” as a proposed mechanistic framework arguing that peer-reviewed evidence can be unified to explain reported biological effects from radiofrequency radiation (RFR) and other non-native EMFs. The post highlights animal studies (notably NTP and Ramazzini) as showing carcinogenic “signals” and emphasizes non-linear dose–response patterns, asserting relevance to regulatory exposure limits. It frames the model as empirically grounded and testable, while acknowledging it is not a complete theory of all EMF effects.

This RF Safe article argues that the “strongest” RF-EMF literature supports concern about cancer-related findings, emphasizing non-monotonic dose–response patterns in the U.S. National Toxicology Program (NTP) rat study and citing additional analyses and animal studies. It reports that FDA evaluations have downplayed the human relevance of NTP results due to high exposures and inconsistencies, and counters that some effects may occur at lower exposure levels than commonly claimed. The piece also references the Ramazzini Institute rat study as supportive evidence at lower whole-body SARs and mentions a 2024 PLOS ONE paper analyzing Ramazzini tumors, but provides limited detail in the excerpt.

RF Safe published a white paper by John Coates arguing that current wireless (RF) exposure limits focus on thermal heating while ignoring “non-thermal” biological effects reported in many studies. The piece cites animal studies (U.S. National Toxicology Program and Ramazzini Institute) and links RF exposure to outcomes such as rare tumors and declining sperm counts, and it alleges regulatory capture. It promotes Li‑Fi and other “biologically compatible” connectivity as a proposed path forward.

RF Safe’s “Executive Summary” argues that non-thermal radiofrequency/microwave exposures from modern wireless technologies can disrupt biological processes, proposing ion-channel voltage-sensor interference as a key mechanism leading to oxidative stress and inflammation. It cites animal studies (NTP and Ramazzini) and claims a WHO-commissioned 2025 systematic review found “high certainty” evidence of increased cancer in animals, and it points to epidemiological trends as suggestive. The piece also criticizes U.S. regulation as focused on thermal effects, highlighting FCC limits dating to 1996 and referencing a 2021 U.S. court ruling that faulted the FCC for not addressing non-thermal evidence.

RF Safe argues that an FDA-authorized therapeutic radiofrequency device (TheraBionic P1) demonstrates biologically meaningful “non-thermal” RF effects, and contrasts this with consumer wireless regulation that it says is based primarily on heating (SAR) limits set in 1996. The post frames this as a regulatory and legal gap, citing the Radiation Control for Health and Safety Act and Telecommunications Act Section 704 as factors limiting local and public-health oversight. It also references several epidemiology and animal studies (e.g., Interphone, Hardell, CERENAT, IARC 2011 classification, and the U.S. NTP rodent studies) to support the claim that non-thermal effects and health risks warrant stronger scrutiny, though the article’s presentation is advocacy-oriented.

This scoping review evaluates evidence on mobile phone electromagnetic exposure and its effects on brain oscillations and cortical excitability in healthy individuals. Across 78 EEG studies (and 2 TMS studies), the authors report that exposure may be linked to changes in neural activity, including increased amplitudes in several EEG bands and possible changes in cortical silent period. However, substantial methodological inconsistency across studies limits firm conclusions, and the review highlights limited evidence for 5G/mmWave exposures and argues for precaution and potential guideline revision.